Delivering Innovative Cancer Diagnostics and Treatments to Patients

Chair: Dr Monica Darnbrough CBE - Member of Board of Directors, Newton’s Apple and formerly Director of Bioscience Unit, Department of Trade and Industry

Aisling Burnand MBE - Member of Board of Directors, Newton's Apple and CEO of the BioIndustry Association

Alan Maine - UK Public Affairs for Merck, Sharp and Dohme

Charlotte Bevan - Senior Lecturer and Head of the Androgen Signaling Group in the Department of Oncology, Imperial College

Melanie Burfitt - Lymphoma Association

David Cameron - Director of the National Cancer Research Newtork

Fran Balkwill - Centre Lead Translational Oncology,Queen Mary, University of London and Director of the Centre of the Cell

Professor John Masters - Member of the Board of Directors, Newton's Apple and Professor of Experimental Pathology at University College London

Dr Jane Cope - Administrative Director of the National Cancer Research Institute

Louise Hendry - Senior Product Manager, Pfizer

Professor Michael Elves - Chairman of the Board of Directors, Newton's Apple

Dr Richard Tiner - Medical Director, Association of British Pharmaceutical Industry

Dr Tim Sparey - Director of Scientific Liaison Merck, Sharp and Dohme

Catherine Foot - Head of Policy Development, Cancer Research UK

Hilary Jackson - Cancer Research UK

John Ramsey - Vice President Global Product Development, AstraZeneca

Alastair Whitington - Network Director, South East London Cancer Network